|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/47 | (2006.01) |
| A61K 31/445 | (2006.01) |
| (11) | Number of the document | 3957320 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21174249.9 |
| Date of filing the European patent application | 2016-12-29 | |
| (97) | Date of publication of the European application | 2022-02-23 |
| (45) | Date of publication and mention of the grant of the patent | 2023-08-23 |
| (46) | Date of publication of the claims translation | 2023-12-11 |
| (30) | Number | Date | Country code |
| 201562272890 P | 2015-12-30 | US | |
| 201662300479 P | 2016-02-26 | US | |
| 201662315412 P | 2016-03-30 | US | |
| 201662402454 P | 2016-09-30 | US | |
| 201662428867 P | 2016-12-01 | US | |
| 201662431791 P | 2016-12-08 | US |
| (72) |
DO, Hung V. , US
KHANNA, Richie , US
GOTSCHALL, Russell , US
|
| (73) |
Amicus Therapeutics, Inc. ,
3675 Market Street, Philadelphia, PA 19104,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Patobulinta rūgštinė alfa-gliukozidazė Pompe ligos gydymui |
| AUGMENTED ACID ALPHA-GLUCOSIDASE FOR THE TREATMENT OF POMPE DISEASE |
| Payment date | Validity (years) | Amount | |
| 2024-11-25 | 9 | 208.00 EUR |
| 2025-12-29 |